Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review.

  title={Cell-derived microparticles and vascular pregnancy complications: a systematic and comprehensive review.},
  author={J. Alijotas‐Reig and C. Palacio-Garc{\'i}a and E. Llurba and M. Vilardell-Tarr{\'e}s},
  journal={Fertility and sterility},
  volume={99 2},
  • J. Alijotas‐Reig, C. Palacio-García, +1 author M. Vilardell-Tarrés
  • Published 2013
  • Medicine
  • Fertility and sterility
  • OBJECTIVE To assess current studies on the relationship between cell-derived microparticles (cMP) and recurrent miscarriages (RM) and pre-eclampsia (PE), and review the relationships between cMP and inflammatory and clot pathways, antiphospholipid antibodies (aPL), cytokines, and pregnancy complications. DESIGN Systematic and comprehensive review of the literature from January 2000 to January 2012. SETTING Vall d'Hebron University Hospital. PATIENT(S) Women with recurrent miscarriages or… CONTINUE READING
    33 Citations
    Evaluation of plasma endothelial microparticles in pre-eclampsia
    • 7
    Origin and levels of circulating microparticles in normal pregnancy: A longitudinal observation in healthy women
    • 12
    Circulating microparticles in umbilical cord blood in normal pregnancy and pregnancy with preeclampsia.
    • 24
    Extracellular Vesicles in the Antiphospholipid Syndrome.
    • 12
    Placental Microparticles and MicroRNAs in Pregnant Women with Plasmodium falciparum or HIV Infection
    • 21


    Prevalence of circulating procoagulant microparticles in women with recurrent miscarriage: a case-controlled study.
    • 73
    • PDF
    Circulating microparticles, lupus anticoagulant and recurrent miscarriages.
    • 21
    Plasma levels of microparticles at 24 weeks of gestation do not predict subsequent pregnancy complications.
    • 10
    Endothelial microparticles: a potential contribution to the thrombotic complications of the antiphospholipid syndrome.
    • 219
    • PDF
    [Endothelial microparticles in preeclampsia and eclampsia].
    • 12
    Circulating procoagulant microparticles in women with unexplained pregnancy loss: a new insight.
    • 110
    Cell-Derived Microparticles and Complement Activation in Preeclampsia Versus Normal Pregnancy
    • 27
    Endothelial and platelet microparticles in vasculitis of the young.
    • 183